125 related articles for article (PubMed ID: 8538625)
1. Protein serine/threonine phosphatases as binding proteins for okadaic acid.
Nagao M; Shima H; Nakayasu M; Sugimura T
Mutat Res; 1995 Dec; 333(1-2):173-9. PubMed ID: 8538625
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the PP2A alpha gene mutation in okadaic acid-resistant variants of CHO-K1 cells.
Shima H; Tohda H; Aonuma S; Nakayasu M; DePaoli-Roach AA; Sugimura T; Nagao M
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9267-71. PubMed ID: 7937753
[TBL] [Abstract][Full Text] [Related]
3. Okadaic acid, a protein phosphatase inhibitor, induces sister-chromatid exchanges depending on the presence of bromodeoxyuridine.
Tohda H; Nagao M; Sugimura T; Oikawa A
Mutat Res; 1993 Oct; 289(2):275-80. PubMed ID: 7690896
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of PP2A, but not PP5, mediates p53 activation by low levels of okadaic acid in rat liver epithelial cells.
Messner DJ; Romeo C; Boynton A; Rossie S
J Cell Biochem; 2006 Sep; 99(1):241-55. PubMed ID: 16598789
[TBL] [Abstract][Full Text] [Related]
5. Mutation induction by okadaic acid, a protein phosphatase inhibitor, in CHL cells, but not in S. typhimurium.
Aonuma S; Ushijima T; Nakayasu M; Shima H; Sugimura T; Nagao M
Mutat Res; 1991; 250(1-2):375-81. PubMed ID: 1658641
[TBL] [Abstract][Full Text] [Related]
6. Role of protein phosphatases in malignant transformation.
Nagao M; Sakai R; Kitagawa Y; Ikeda I; Sasaki K; Shima H; Sugimura T
Princess Takamatsu Symp; 1989; 20():177-84. PubMed ID: 2562181
[TBL] [Abstract][Full Text] [Related]
7. Analysis by in vitro mutagenesis of PP2A alpha okadaic acid responsive sequences.
Kaneko S; Shima H; Amagasa T; Takagi M; Sugimura T; Nagao M
Biochem Biophys Res Commun; 1995 Sep; 214(2):518-23. PubMed ID: 7677760
[TBL] [Abstract][Full Text] [Related]
8. Ras mutation, irrespective of cell type and p53 status, determines a cell's destiny to undergo apoptosis by okadaic acid, an inhibitor of protein phosphatase 1 and 2A.
Rajesh D; Schell K; Verma AK
Mol Pharmacol; 1999 Sep; 56(3):515-25. PubMed ID: 10462539
[TBL] [Abstract][Full Text] [Related]
9. Human leukemia K562 cell mutant (K562/OA200) selected for resistance to okadaic acid (protein phosphatase inhibitor) lacks protein kinase C-epsilon, exhibits multidrug resistance phenotype, and expresses drug pump P-glycoprotein.
Zheng B; Chambers TC; Raynor RL; Markham PN; Gebel HM; Vogler WR; Kuo JF
J Biol Chem; 1994 Apr; 269(16):12332-8. PubMed ID: 7512966
[TBL] [Abstract][Full Text] [Related]
10. An alternative theory of tissue specificity by tumor promotion of okadaic acid in glandular stomach of SD rats.
Suganuma M; Tatematsu M; Yatsunami J; Yoshizawa S; Okabe S; Uemura D; Fujiki H
Carcinogenesis; 1992 Oct; 13(10):1841-5. PubMed ID: 1330344
[TBL] [Abstract][Full Text] [Related]
11. Gene amplification and multidrug resistance induced by the phosphatase-inhibitory tumor promoter, okadaic acid.
Wang SJ; Scavetta R; Lenz HJ; Danenberg K; Danenberg PV; Schönthal AH
Carcinogenesis; 1995 Mar; 16(3):637-41. PubMed ID: 7697825
[TBL] [Abstract][Full Text] [Related]
12. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
[TBL] [Abstract][Full Text] [Related]
13. Protein phosphatase inhibitors induce the selective breakdown of stable microtubules in fibroblasts and epithelial cells.
Gurland G; Gundersen GG
Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8827-31. PubMed ID: 8415615
[TBL] [Abstract][Full Text] [Related]
14. Protein phosphatase-1 inhibition induces high SCEs in normal whole blood cultures.
Mann RK; Bamezai R
Indian J Exp Biol; 1995 Sep; 33(9):710-1. PubMed ID: 8557315
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterisation of a type-1 protein phosphatase from the okadaic acid-producing marine dinoflagellate Prorocentrum lima.
Boland MP; Taylor MF; Holmes CF
FEBS Lett; 1993 Nov; 334(1):13-7. PubMed ID: 8224216
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship within a series of okadaic acid derivatives.
Nishiwaki S; Fujiki H; Suganuma M; Furuya-Suguri H; Matsushima R; Iida Y; Ojika M; Yamada K; Uemura D; Yasumoto T
Carcinogenesis; 1990 Oct; 11(10):1837-41. PubMed ID: 2170047
[TBL] [Abstract][Full Text] [Related]
17. Protein phosphatase types 1 and/or 2A regulate nucleocytoplasmic shuttling of glucocorticoid receptors.
DeFranco DB; Qi M; Borror KC; Garabedian MJ; Brautigan DL
Mol Endocrinol; 1991 Sep; 5(9):1215-28. PubMed ID: 1663212
[TBL] [Abstract][Full Text] [Related]
18. [Minisatellite instability induced by okadaic acid].
Kaneko S
Kokubyo Gakkai Zasshi; 1997 Mar; 64(1):12-23. PubMed ID: 9125847
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of protein serine/threonine phosphatases by fumonisin B1, a mycotoxin.
Fukuda H; Shima H; Vesonder RF; Tokuda H; Nishino H; Katoh S; Tamura S; Sugimura T; Nagao M
Biochem Biophys Res Commun; 1996 Mar; 220(1):160-5. PubMed ID: 8602837
[TBL] [Abstract][Full Text] [Related]
20. Contrasting effects of two tumour promoters, phorbol myristate acetate and okadaic acid, on T-cell responses and activation of p42 MAP-kinase/ERK-2.
Amaral MC; Casillas AM; Nel AE
Immunology; 1993 May; 79(1):24-31. PubMed ID: 8389730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
